drugset
drugset / Trial / NCT07088913

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants

NCT07088913 ↗

Phase 1 Completed 20 enrolled AstraZeneca Parexel · collab
Non-randomizedSequentialOpen-labelOther

Summary

The purpose of the study is to assess the effect of capivasertib on the pharmacokinetics (PK) of oral rosuvastatin in healthy participants.

Timeline

Start
2025-07-28
Primary completion
2026-02-20
Completion
2026-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Capivasertib Small molecule — Oral
Subject Rosuvastatin Small molecule — Oral

Indications

No indication recorded.